XTL Biopharmaceuticals Ltd (XTLB)
2.74
+0.17
(+6.61%)
USD |
NASDAQ |
May 15, 16:00
2.74
0.00 (0.00%)
After-Hours: 20:00
XTL Biopharmaceuticals Price to Book Value: 6.725 for May 15, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 14, 2024 | 6.308 |
| May 13, 2024 | 7.167 |
| May 10, 2024 | 6.284 |
| May 09, 2024 | 5.891 |
| May 08, 2024 | 6.014 |
| May 07, 2024 | 6.259 |
| May 06, 2024 | 6.21 |
| May 03, 2024 | 6.21 |
| May 02, 2024 | 6.198 |
| May 01, 2024 | 6.382 |
| April 30, 2024 | 6.357 |
| April 29, 2024 | 5.94 |
| April 26, 2024 | 5.945 |
| April 25, 2024 | 5.891 |
| April 24, 2024 | 6.284 |
| April 23, 2024 | 6.357 |
| April 22, 2024 | 6.505 |
| April 19, 2024 | 5.989 |
| April 18, 2024 | 5.989 |
| April 17, 2024 | 6.063 |
| April 16, 2024 | 6.382 |
| April 15, 2024 | 6.578 |
| April 12, 2024 | 6.382 |
| April 11, 2024 | 6.775 |
| April 10, 2024 | 6.824 |
| Date | Value |
|---|---|
| April 09, 2024 | 7.806 |
| April 08, 2024 | 7.732 |
| April 05, 2024 | 8.002 |
| April 04, 2024 | 7.634 |
| April 03, 2024 | 8.174 |
| April 02, 2024 | 6.922 |
| April 01, 2024 | 7.388 |
| March 28, 2024 | 6.897 |
| March 27, 2024 | 6.627 |
| March 26, 2024 | 7.536 |
| March 25, 2024 | 6.897 |
| March 22, 2024 | 6.431 |
| March 21, 2024 | 5.94 |
| March 20, 2024 | 5.842 |
| March 19, 2024 | 2.553 |
| March 18, 2024 | 2.845 |
| March 15, 2024 | 2.16 |
| March 14, 2024 | 2.170 |
| March 13, 2024 | 2.332 |
| March 12, 2024 | 2.356 |
| March 11, 2024 | 2.356 |
| March 08, 2024 | 2.258 |
| March 07, 2024 | 2.086 |
| March 06, 2024 | 2.232 |
| March 05, 2024 | 2.233 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6741
Minimum
Apr 06 2020
8.368
Maximum
Sep 02 2021
2.521
Average
1.905
Median
Jul 24 2023
Price to Book Value Benchmarks
| Compugen Ltd | 3.011 |
| Pluri Inc | -- |
| BioLine Rx Ltd | 3.718 |
| Can Fite Biofarma Ltd | 1.647 |
| BiomX Inc | 6.363 |
Price to Book Value Related Metrics
| Price | 2.74 |
| Earnings Yield | -10.95% |
| Market Cap | 14.93M |